Tedavi Sırasında Ortaya Çıkan Santral Uyku Apne

Yazarlar

Mehmet Emin Sezgin

Özet

Tedaviyle ortaya çıkan santral uyku apne (TOSUA), obstrüktif uyku apne sendromu (OSAS) tanılı hastalarda pozitif hava yolu basıncı (PAP) tedavisiyle obstrüktif olayların giderilmesi sonucu santral apne ve hipopnelerin gelişmesiyle karakterize bir tablodur. OSAS nedeniyle PAP uygulanan hastaların %5-15'inde görülen bu bozukluğun tanısı için polisomnografi (PSG) yeterlidir. Erkek cinsiyet, düşük vücut kitle indeksi, kalp yetmezliği, ileri yaş, supin pozisyonu ve yüksek CPAP ayarı önemli risk faktörleri arasındadır. Patofizyolojisinde artmış kemosensitivite, hipokapni, uykuda solunum kontrol düzensizliği ve "loop gain" (ventilatuvar döngü kazancı) mekanizmaları rol oynar. TOSUA hastaları asemptomatik olabileceği gibi gündüz aşırı uyku hali, kötü uyku kalitesi, yorgunluk ve sabah baş ağrıları gibi OSAS semptomları da gösterebilir. Birçok hastada 2-3 aylık CPAP tedavisiyle kendiliğinden iyileşme gözlenirken, iyileşmeyen ve dirençli vakalarda adaptif servo-ventilasyon (ASV) veya iki seviyeli pozitif hava yolu basıncı (BiPAP) modlarına geçiş yapılması önerilir. Ayrıca tedaviye oksijen ve pozisyonel yaklaşımlar da eklenebilir.

Treatment-emergent central sleep apnea (TECSA) is characterized by the emergence and persistence of central apneas and hypopneas following the resolution of obstructive events with positive airway pressure (PAP) therapy in patients with obstructive sleep apnea syndrome (OSAS). Occurring in approximately 5% to 15% of OSAS patients undergoing PAP therapy, its diagnosis relies on polysomnography (PSG). Risk factors include male gender, lower body mass index, heart failure, advanced age, supine position, and high CPAP settings. Although the exact pathophysiology remains unknown, increased chemosensitivity, hypocapnia, sleep instability, and high ventilatory loop gain are highly implicated. Patients may be asymptomatic or present with OSAS-like symptoms, including excessive daytime sleepiness, poor sleep quality, fatigue, and morning headaches. Most TECSA cases resolve spontaneously after 2 to 3 months of continuous CPAP therapy. For persistent cases, switching to adaptive servo-ventilation (ASV) or bilevel positive airway pressure (BiPAP) modes is recommended, as ASV dynamically adjusts pressure support to prevent central events. Supplemental oxygen and positional therapy can also be integrated into the treatment.

Referanslar

American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, American Academy of Sleep Medicine, Darien, IL 2014.

Nigam G, Pathak C, Riaz M. A systematic review on treatment-emergent central sleep apnea. Ann Thorac Med. 2016;11(3): 202-210.

Liu, Dongquan, et al. "Trajectories of emergent central sleep apnea during CPAP therapy." Chest 152.4 (2017): 751-760.

Nussbaumer-Ochsner Y, Schuepfer N, Ulrich S, Bloch KE. Rakımda obstrüktif uyku apne sendromlu hastalarda sık görülen merkezi olaylarla uyku apnesinin alevlenmesi: randomize bir çalışma. Thorax 2010; 65: 429.

Malhotra A, Bertisch S, Wellman A. Karmaşık uyku apnesi: bu gerçekten bir hastalık değil. J Clin Sleep Med 2008; 4: 406.

Javaheri S, Smith J, Chung E.Karmaşık uyku apnesinin prevalansı ve doğal seyri. J Clin Sleep Med 2009; 5: 205.

Ambrogio C, Lowman X, Kuo M, ve diğerleri. Kronik solunum yetmezliği olan hastalarda uyku ve non-invaziv ventilasyon. Yoğun Bakım Med 2009; 35: 306.

Meza S, Mendez M, Ostrowski M, Younes M. Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. J Appl Physiol (1985) 1998; 85:1929.

Dempsey JA. Crossing the apnoeic threshold: causes and consequences. Exp Physiol 2005; 90:13.

Skatrud JB, Dempsey JA, Badr S, Begle RL. Effect of airway impedance on CO2 retention and respiratory muscle activity during NREM sleep. J Appl Physiol (1985) 1988; 65:1676.

Orr, Jeremy E., et al. “Pathogenesis of Central and Complex Sleep Apnoea.” Respirology, vol. 22, no. 1, 2017, pp. 43–52.

Eckert DJ, Jordan AS, Merchia P, Malhotr A. Central sleep apnea. Pathophysiology and treatment. Chest 2007; 131: 5

Johnson KG, Johnson DC. Bilevel positive airway pressure worsens central apneas during sleep. Chest 2005; 128:2141..

Chowdhuri S, Shanidze I, Pierchala L, et al. Effect of episodic hypoxia on the susceptibility to hypocapnic central apnea during NREM sleep. J Appl Physiol (1985) 2010; 108:369.

Salloum A, Rowley JA, Mateika JH, et al. Increased propensity for central apnea in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure. Am J Respir Crit Care Med 2010; 181:189.

Montesi SB, Bakker JP, Macdonald M, et al. Air leak during CPAP titration as a risk factor for central apnea. J Clin Sleep Med 2013; 9:1187.

Cassel W, Canisius S, Becker HF, et al. A prospective polysomnographic study on the evolution of complex sleep apnoea. Eur Respir J 2011; 38:329.

Allam JS, Olson EJ, Gay PC, Morgenthaler TI. Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes. Chest 2007; 132:1839.

Thomas RJ, Terzano MG, Parrino L, Weiss JW. Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern--a recognizable polysomnographic variant with practical clinical implications. Sleep 2004; 27:229.

Morgenthaler TI, Kuzniar TJ, Wolfe LF, et al. The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep 2014; 37:927.

Stanchina M, Robinson K, Corrao W, Donat W, Sands S, Malhotra A. Clinical Use of Loop Gain Measures to Determine Continuous Positive Airway Pressure Efficacy in Patients with Complex Sleep Apnea. A Pilot Study. Ann Am Thorac Soc 2015;12:1351-7.

Dellweg D, Kerl J, Hoehn E, et al. Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep 2013; 36:1163.

Arzt M, Wensel R, Montalvan S, et al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest 2008; 134:61.

Orr J, Javaheri S, Malhotra A. Comparative effectiveness research in complex sleep apnea. Sleep 2014; 37:833.

Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR,Lamm CI, et al. The treatment of central sleep apnea syn-dromes in adults: practice parameters with an evidence-basedliterature review and meta-analyses. Sleep 2012;35:17-40

Sayfalar

203-207

Gelecek

25 Mayıs 2022

Lisans

Lisans